AU2022404954A1 - Heart valve sealing devices and delivery devices therefor - Google Patents
Heart valve sealing devices and delivery devices therefor Download PDFInfo
- Publication number
- AU2022404954A1 AU2022404954A1 AU2022404954A AU2022404954A AU2022404954A1 AU 2022404954 A1 AU2022404954 A1 AU 2022404954A1 AU 2022404954 A AU2022404954 A AU 2022404954A AU 2022404954 A AU2022404954 A AU 2022404954A AU 2022404954 A1 AU2022404954 A1 AU 2022404954A1
- Authority
- AU
- Australia
- Prior art keywords
- actuation
- latch
- view
- implant
- tube
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 210000003709 heart valve Anatomy 0.000 title claims abstract description 93
- 238000007789 sealing Methods 0.000 title description 5
- 230000014759 maintenance of location Effects 0.000 claims description 582
- 230000007246 mechanism Effects 0.000 claims description 335
- 230000008878 coupling Effects 0.000 claims description 290
- 238000010168 coupling process Methods 0.000 claims description 290
- 238000005859 coupling reaction Methods 0.000 claims description 290
- 230000008439 repair process Effects 0.000 claims description 236
- 230000033001 locomotion Effects 0.000 claims description 232
- 230000000295 complement effect Effects 0.000 claims description 32
- 230000006835 compression Effects 0.000 claims description 29
- 238000007906 compression Methods 0.000 claims description 29
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 claims description 14
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims description 7
- 230000005855 radiation Effects 0.000 claims description 7
- 239000007943 implant Substances 0.000 abstract description 624
- 238000002513 implantation Methods 0.000 abstract description 114
- 239000000463 material Substances 0.000 description 197
- 210000001519 tissue Anatomy 0.000 description 162
- 210000004115 mitral valve Anatomy 0.000 description 86
- 125000006850 spacer group Chemical group 0.000 description 76
- 230000007704 transition Effects 0.000 description 73
- 238000000034 method Methods 0.000 description 69
- 229910052751 metal Inorganic materials 0.000 description 61
- 239000002184 metal Substances 0.000 description 60
- 230000001965 increasing effect Effects 0.000 description 52
- 210000002414 leg Anatomy 0.000 description 46
- 239000004744 fabric Substances 0.000 description 42
- 239000000945 filler Substances 0.000 description 37
- 229910001285 shape-memory alloy Inorganic materials 0.000 description 33
- 239000008280 blood Substances 0.000 description 32
- 210000004369 blood Anatomy 0.000 description 32
- 210000003698 chordae tendineae Anatomy 0.000 description 32
- 210000005246 left atrium Anatomy 0.000 description 32
- 210000005240 left ventricle Anatomy 0.000 description 32
- 229910001000 nickel titanium Inorganic materials 0.000 description 32
- 206010067171 Regurgitation Diseases 0.000 description 31
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 29
- 230000003993 interaction Effects 0.000 description 24
- 239000000853 adhesive Substances 0.000 description 22
- 230000001070 adhesive effect Effects 0.000 description 22
- 238000000576 coating method Methods 0.000 description 22
- 230000036961 partial effect Effects 0.000 description 21
- 210000000591 tricuspid valve Anatomy 0.000 description 19
- 230000001746 atrial effect Effects 0.000 description 18
- 239000011248 coating agent Substances 0.000 description 18
- 230000007423 decrease Effects 0.000 description 17
- 230000008569 process Effects 0.000 description 17
- 230000002829 reductive effect Effects 0.000 description 17
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 16
- 239000004033 plastic Substances 0.000 description 16
- 229920003023 plastic Polymers 0.000 description 16
- 239000000843 powder Substances 0.000 description 16
- MWCLLHOVUTZFKS-UHFFFAOYSA-N Methyl cyanoacrylate Chemical compound COC(=O)C(=C)C#N MWCLLHOVUTZFKS-UHFFFAOYSA-N 0.000 description 15
- 230000008901 benefit Effects 0.000 description 14
- 230000017531 blood circulation Effects 0.000 description 14
- 238000007648 laser printing Methods 0.000 description 14
- 230000002861 ventricular Effects 0.000 description 13
- 230000006870 function Effects 0.000 description 12
- 238000003698 laser cutting Methods 0.000 description 12
- 206010027727 Mitral valve incompetence Diseases 0.000 description 11
- 210000001765 aortic valve Anatomy 0.000 description 11
- 230000005540 biological transmission Effects 0.000 description 11
- 230000008602 contraction Effects 0.000 description 11
- 230000000717 retained effect Effects 0.000 description 11
- 210000005245 right atrium Anatomy 0.000 description 10
- 230000006378 damage Effects 0.000 description 9
- 229920000642 polymer Polymers 0.000 description 9
- 210000005241 right ventricle Anatomy 0.000 description 9
- 230000008859 change Effects 0.000 description 8
- 239000000835 fiber Substances 0.000 description 8
- 210000003127 knee Anatomy 0.000 description 8
- 230000007257 malfunction Effects 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 239000002245 particle Substances 0.000 description 8
- 230000009467 reduction Effects 0.000 description 8
- 238000004088 simulation Methods 0.000 description 8
- 238000012546 transfer Methods 0.000 description 8
- -1 CuAlNi Inorganic materials 0.000 description 7
- 208000031481 Pathologic Constriction Diseases 0.000 description 7
- 238000005520 cutting process Methods 0.000 description 7
- 210000003540 papillary muscle Anatomy 0.000 description 7
- 230000037361 pathway Effects 0.000 description 7
- 239000007787 solid Substances 0.000 description 7
- 239000010959 steel Substances 0.000 description 7
- 230000036262 stenosis Effects 0.000 description 7
- 208000037804 stenosis Diseases 0.000 description 7
- 238000003466 welding Methods 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 6
- 239000000956 alloy Substances 0.000 description 6
- 238000006073 displacement reaction Methods 0.000 description 6
- 239000002861 polymer material Substances 0.000 description 6
- 210000003102 pulmonary valve Anatomy 0.000 description 6
- 238000011282 treatment Methods 0.000 description 6
- 230000000007 visual effect Effects 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 210000003484 anatomy Anatomy 0.000 description 5
- 238000005266 casting Methods 0.000 description 5
- 238000010276 construction Methods 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 239000013013 elastic material Substances 0.000 description 5
- 210000002837 heart atrium Anatomy 0.000 description 5
- 239000012528 membrane Substances 0.000 description 5
- 150000002739 metals Chemical class 0.000 description 5
- 238000000465 moulding Methods 0.000 description 5
- 238000001356 surgical procedure Methods 0.000 description 5
- 239000004753 textile Substances 0.000 description 5
- 238000003079 width control Methods 0.000 description 5
- 229910000831 Steel Inorganic materials 0.000 description 4
- 230000035602 clotting Effects 0.000 description 4
- 235000004879 dioscorea Nutrition 0.000 description 4
- 229920001971 elastomer Polymers 0.000 description 4
- 230000005684 electric field Effects 0.000 description 4
- 239000000017 hydrogel Substances 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 239000010410 layer Substances 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 230000000451 tissue damage Effects 0.000 description 4
- 231100000827 tissue damage Toxicity 0.000 description 4
- MOWXJLUYGFNTAL-DEOSSOPVSA-N (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol Chemical compound N1=NC(OC)=CC=C1[C@@H](O)C1=CC(C=2C3=CC=C(C=C3N=CN=2)N2CCOCC2)=C(F)C=C1Cl MOWXJLUYGFNTAL-DEOSSOPVSA-N 0.000 description 3
- 229910000851 Alloy steel Inorganic materials 0.000 description 3
- 208000012287 Prolapse Diseases 0.000 description 3
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 229910045601 alloy Inorganic materials 0.000 description 3
- 238000005452 bending Methods 0.000 description 3
- 229910052802 copper Inorganic materials 0.000 description 3
- 238000002716 delivery method Methods 0.000 description 3
- 229910003460 diamond Inorganic materials 0.000 description 3
- 239000010432 diamond Substances 0.000 description 3
- 230000003205 diastolic effect Effects 0.000 description 3
- 230000010339 dilation Effects 0.000 description 3
- 239000000806 elastomer Substances 0.000 description 3
- 206010014665 endocarditis Diseases 0.000 description 3
- 239000002657 fibrous material Substances 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 239000012781 shape memory material Substances 0.000 description 3
- 230000002966 stenotic effect Effects 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 2
- KCBWAFJCKVKYHO-UHFFFAOYSA-N 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine Chemical compound C1(CC1)C1=NC=NC(=C1C1=NC=C2C(=N1)N(N=C2)CC1=CC=C(C=C1)C=1N(C=C(N=1)C(F)(F)F)C(C)C)OC KCBWAFJCKVKYHO-UHFFFAOYSA-N 0.000 description 2
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 2
- 206010053567 Coagulopathies Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 210000000709 aorta Anatomy 0.000 description 2
- 230000000712 assembly Effects 0.000 description 2
- 238000000429 assembly Methods 0.000 description 2
- 239000012620 biological material Substances 0.000 description 2
- 238000004891 communication Methods 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000013536 elastomeric material Substances 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 230000002458 infectious effect Effects 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 238000003754 machining Methods 0.000 description 2
- 230000013011 mating Effects 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 210000003492 pulmonary vein Anatomy 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 238000007493 shaping process Methods 0.000 description 2
- 239000002356 single layer Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000011179 visual inspection Methods 0.000 description 2
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 1
- BYHQTRFJOGIQAO-GOSISDBHSA-N 3-(4-bromophenyl)-8-[(2R)-2-hydroxypropyl]-1-[(3-methoxyphenyl)methyl]-1,3,8-triazaspiro[4.5]decan-2-one Chemical compound C[C@H](CN1CCC2(CC1)CN(C(=O)N2CC3=CC(=CC=C3)OC)C4=CC=C(C=C4)Br)O BYHQTRFJOGIQAO-GOSISDBHSA-N 0.000 description 1
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
- 238000010146 3D printing Methods 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 208000031229 Cardiomyopathies Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 208000010496 Heart Arrest Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 201000001943 Tricuspid Valve Insufficiency Diseases 0.000 description 1
- 206010044640 Tricuspid valve incompetence Diseases 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 230000004323 axial length Effects 0.000 description 1
- 210000004763 bicuspid Anatomy 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000003683 cardiac damage Effects 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 210000000080 chela (arthropods) Anatomy 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000004512 die casting Methods 0.000 description 1
- 230000003292 diminished effect Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 238000004146 energy storage Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000003191 femoral vein Anatomy 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000005242 forging Methods 0.000 description 1
- 239000003102 growth factor Substances 0.000 description 1
- 230000010247 heart contraction Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000005986 heart dysfunction Effects 0.000 description 1
- 208000018578 heart valve disease Diseases 0.000 description 1
- 238000003780 insertion Methods 0.000 description 1
- 230000037431 insertion Effects 0.000 description 1
- 230000002452 interceptive effect Effects 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 239000002648 laminated material Substances 0.000 description 1
- 238000003475 lamination Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000036244 malformation Effects 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 208000015122 neurodegenerative disease Diseases 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 238000005192 partition Methods 0.000 description 1
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 1
- 229920006254 polymer film Polymers 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 210000001147 pulmonary artery Anatomy 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 239000012858 resilient material Substances 0.000 description 1
- 208000004124 rheumatic heart disease Diseases 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010902 straw Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 229920002994 synthetic fiber Polymers 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 210000001631 vena cava inferior Anatomy 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2463—Implants forming part of the valve leaflets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/246—Devices for obstructing a leak through a native valve in a closed condition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2442—Annuloplasty rings or inserts for correcting the valve shape; Implants for improving the function of a native heart valve
- A61F2/2466—Delivery devices therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0091—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements connected by a hinged linkage mechanism, e.g. of the single-bar or multi-bar linkage type
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Prostheses (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163287907P | 2021-12-09 | 2021-12-09 | |
| US63/287,907 | 2021-12-09 | ||
| PCT/US2022/051232 WO2023107296A1 (en) | 2021-12-09 | 2022-11-29 | Heart valve sealing devices and delivery devices therefor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2022404954A1 true AU2022404954A1 (en) | 2024-05-09 |
Family
ID=85018010
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2022404954A Pending AU2022404954A1 (en) | 2021-12-09 | 2022-11-29 | Heart valve sealing devices and delivery devices therefor |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240335286A1 (https=) |
| EP (1) | EP4444223A1 (https=) |
| JP (1) | JP2024546738A (https=) |
| KR (1) | KR20240111807A (https=) |
| CN (1) | CN118678935A (https=) |
| AU (1) | AU2022404954A1 (https=) |
| CA (1) | CA3237990A1 (https=) |
| MX (1) | MX2024005056A (https=) |
| WO (1) | WO2023107296A1 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021071682A1 (en) * | 2019-10-09 | 2021-04-15 | Edwards Lifesciences Corporation | Heart valve sealing devices and delivery devices therefor |
| AU2023335894A1 (en) | 2022-09-02 | 2025-02-27 | Edwards Lifesciences Corporation | Heart valve repair devices and delivery devices therefor |
| WO2025059278A1 (en) | 2023-09-13 | 2025-03-20 | Edwards Lifesciences Corporation | Heart valve repair devices and delivery devices therefor |
| WO2025064233A1 (en) | 2023-09-18 | 2025-03-27 | Edwards Lifesciences Corporation | Heart valve repair devices and delivery devices therefor |
| WO2025085321A1 (en) | 2023-10-19 | 2025-04-24 | Edwards Lifesciences Corporation | Systems and methods for treating a native valve |
| WO2025106329A1 (en) | 2023-11-16 | 2025-05-22 | Edwards Lifesciences Corporation | Heart valve repair devices and delivery devices therefor |
| WO2025264463A1 (en) | 2024-06-18 | 2025-12-26 | Edwards Lifesciences Corporation | Heart valve repair devices and delivery devices therefor |
| WO2026075887A1 (en) | 2024-10-01 | 2026-04-09 | Edwards Lifesciences Corporation | Heart valve repair devices and delivery devices therefor |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10517719B2 (en) | 2008-12-22 | 2019-12-31 | Valtech Cardio, Ltd. | Implantation of repair devices in the heart |
| US8449599B2 (en) | 2009-12-04 | 2013-05-28 | Edwards Lifesciences Corporation | Prosthetic valve for replacing mitral valve |
| US9510946B2 (en) | 2012-09-06 | 2016-12-06 | Edwards Lifesciences Corporation | Heart valve sealing devices |
| US9439763B2 (en) | 2013-02-04 | 2016-09-13 | Edwards Lifesciences Corporation | Prosthetic valve for replacing mitral valve |
| EP4420635B1 (en) | 2015-05-14 | 2025-09-24 | Edwards Lifesciences Corporation | Heart valve sealing devices and delivery devices therefor |
| SG11201907076YA (en) * | 2017-04-18 | 2019-08-27 | Edwards Lifesciences Corp | Heart valve sealing devices and delivery devices therefor |
| US11224511B2 (en) * | 2017-04-18 | 2022-01-18 | Edwards Lifesciences Corporation | Heart valve sealing devices and delivery devices therefor |
| LT3964175T (lt) | 2018-01-09 | 2024-10-25 | Edwards Lifesciences Corporation | Įgimto vožtuvo taisymo įtaisai |
| US10945844B2 (en) | 2018-10-10 | 2021-03-16 | Edwards Lifesciences Corporation | Heart valve sealing devices and delivery devices therefor |
| WO2020236735A1 (en) * | 2019-05-20 | 2020-11-26 | Edwards Lifesciences Corporation | Heart valve sealing devices, delivery devices therefor, and retrieval devices |
-
2022
- 2022-11-29 WO PCT/US2022/051232 patent/WO2023107296A1/en not_active Ceased
- 2022-11-29 MX MX2024005056A patent/MX2024005056A/es unknown
- 2022-11-29 EP EP22846965.6A patent/EP4444223A1/en active Pending
- 2022-11-29 JP JP2024534348A patent/JP2024546738A/ja active Pending
- 2022-11-29 CN CN202280087682.7A patent/CN118678935A/zh active Pending
- 2022-11-29 AU AU2022404954A patent/AU2022404954A1/en active Pending
- 2022-11-29 CA CA3237990A patent/CA3237990A1/en active Pending
- 2022-11-29 KR KR1020247022090A patent/KR20240111807A/ko active Pending
-
2024
- 2024-06-07 US US18/737,888 patent/US20240335286A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN118678935A (zh) | 2024-09-20 |
| JP2024546738A (ja) | 2024-12-26 |
| EP4444223A1 (en) | 2024-10-16 |
| US20240335286A1 (en) | 2024-10-10 |
| KR20240111807A (ko) | 2024-07-17 |
| MX2024005056A (es) | 2024-07-19 |
| CA3237990A1 (en) | 2023-06-15 |
| WO2023107296A1 (en) | 2023-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7824300B2 (ja) | 心臓弁修復デバイスおよびそのための送達デバイス | |
| AU2022404954A1 (en) | Heart valve sealing devices and delivery devices therefor | |
| JP7604400B2 (ja) | 心臓弁封止デバイスおよびその送達デバイス | |
| US12551344B2 (en) | Heart valve sealing devices and delivery devices therefor | |
| WO2022036209A1 (en) | Valve repair implant with leaflet tension indication | |
| WO2021202130A1 (en) | High flexibility implant catheter with low compression | |
| JP2024516237A (ja) | 心臓弁処置デバイスのための送達デバイス | |
| US20240415652A1 (en) | Heart valve repair devices and delivery devices therefor | |
| US20240374386A1 (en) | Delivery devices and methods for heart valve repair and replacement devices | |
| CN116710028A (zh) | 心脏瓣膜修复装置及其递送装置 | |
| HK40089905A (zh) | 心脏瓣膜密封装置及其递送装置 | |
| WO2025059278A1 (en) | Heart valve repair devices and delivery devices therefor | |
| WO2025019677A1 (en) | Heart valve repair devices and delivery devices therefor | |
| WO2026030053A2 (en) | Heart valve repair devices and delivery devices therefor | |
| CN118613234A (zh) | 用于心脏瓣膜修复和替换装置的递送装置 | |
| HK40107767A (zh) | 用於心脏瓣膜治疗装置的递送装置 | |
| HK40066518A (zh) | 心脏瓣膜密封装置及其递送装置 | |
| HK40064741B (zh) | 心脏瓣膜密封装置及其递送装置 |